Neoleukin Therapeutics, Inc.
At Close: 4:00 PM
NLTX Stock Price Graph
NLTX Stock Price Today
Neoleukin Therapeutics, Inc. (NLTX) stock rallied over 3.39% intraday to trade at $3.66 a share on NASDAQ. The stock opened with a loss of -6.76% at $3.31 and touched an intraday high of $3.51, rising 3.10% against the last close of $3.55. The Neoleukin Therapeutics, Inc. in stock market went to a low of $3.31 during the session.
NLTX Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
NLTX Stock Price History Chart
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
Frequently Asked Questions
What is the current Neoleukin Therapeutics, Inc. (NLTX) stock price?
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) stock price is $3.66 in the last trading session. During the trading session, NLTX stock reached the peak price of $3.51 while $3.31 was the lowest point it dropped to. The percentage change in NLTX stock occurred in the recent session was 3.39% while the dollar amount for the price change in NLTX stock was $0.12.
NLTX's industry and sector of operation?
The NASDAQ listed NLTX is part of Drug Manufacturers—Specialty & Generic industry that operates in the broader Healthcare sector. Neoleukin Therapeutics, Inc. , a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology.
Who are the executives of NLTX?
Ms. Donna M. Cochener-Metcalfe J.D.
Gen. Counsel & Senior Vice President of Legal
Mr. Sean Michael Smith
Principal Accounting Officer, Vice President of Fin. & Controller
Dr. Bill Arthur
Vice President & Head of Research
Dr. Jonathan G. Drachman M.D.
Chief Executive Officer, Pres, Principal Financial Officer & Director
How NLTX did perform over past 52-week?
NLTX's closing price is 1.37% higher than its 52-week low of $1.875 where as its distance from 52-week high of $4.7 is -0.36%.
How many employees does NLTX have?
Number of NLTX employees currently stands at 56.00. NLTX operates from 188 East Blaine Street, Seattle, WA 98102, US.
Link for NLTX official website?
Official Website of NLTX is: https://www.neoleukin.com
How do I contact NLTX?
How many shares of NLTX are traded daily?
NLTX stock volume for the day was 41880.00 shares. The average number of NLTX shares traded daily for last 3 months was 23.96 Thousands.
What is the market cap of NLTX currently?
The market value of NLTX currently stands at $34.4 Million with its latest stock price at $3.66 and 42.65 Million of its shares outstanding.